K. Damme

Scientific relevance and irrelevance of genetic susceptibility for standard setting in risk control

L. Casteleyn, A. Collard, K. Damme, 2008 .

Ethics and data protection in human biomarker studies.

L. Casteleyn, B. Dumez, An Jamers, 2010 .

Early treatment with inhaled GM-CSF improves oxygenation and anti-viral immunity in COVID-19 induced lung injury – a randomized clinical trial

A. Sette, S. Dupont, R. Seurinck, 2021 .

Ethical Issues in Genetic Screening and Genetic Monitoring of Employees a

P. Vineis, L. Casteleyn, M. Sorsa, 1997, Annals of the New York Academy of Sciences.

Erratum: Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial (Trials (2020) 21 1 (468))

I. Peene, C. Bosteels, M. Vuylsteke, 2020 .

Acceptability of genetic susceptibility testing in occupational health: a position paper

L. Casteleyn, K. Damme, 2004 .